Wegovy Canada: Cost, Availability, and How it Compares to Ozempic

If you’ve been researching weight loss medications in Canada, you’ve likely come across both Wegovy and Ozempic. The two are closely related, as each contains the same active ingredient — semaglutide. However, Wegovy and Ozempic are not the same treatment.

Wegovy is the version of semaglutide that’s actually approved by Health Canada for weight management. Ozempic, on the other hand, has Canadian indications for people with Type 2 Diabetes. Their approved uses, dose schedules and devices differ, so they should not be substituted without advice from your prescriber and pharmacist.

In this article, we’ll cover everything you need to know about Wegovy in Canada, including how it works, how much it costs, insurance coverage, side effects, and when generic alternatives may become available. We also go into detail about the key differences between Ozempic vs Wegovy.

What Is Wegovy?

Wegovy is a brand of semaglutide, a once-weekly injectable medication manufactured by Novo Nordisk. Its usual maintenance dose is 2.4 mg after gradual dose escalation. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking a hormone your body naturally produces to regulate appetite and blood sugar.

Wegovy is specifically approved for chronic weight management in adults with a BMI of 30 or greater (obesity), or a BMI of 27 or greater with at least one weight-related health condition. Wegovy is also approved to reduce non-fatal heart-attack risk in adults with established cardiovascular disease and a BMI of at least 27, and has conditional authorization for non-cirrhotic MASH (metabolic dysfunction-associated steatohepatitis) in adults with moderate to advanced liver fibrosis (stages F2–F3). This indication requires further confirmation of clinical benefit.

The Canadian monograph describes both single-use pens and multi-use FlexTouch pens. With a FlexTouch pen, patients attach a new needle, select the prescribed dose and press the dose button; each pen supplies four weekly doses. Single-use pens have different instructions. Check which device your pharmacy dispenses and ask for a demonstration.

How Does Wegovy Work for Weight Loss?

Wegovy works through the same mechanisms as other semaglutide-based GLP-1 medications. If you’ve already read our guide to Ozempic, the science will be familiar, but here’s a brief overview.

Semaglutide (the key ingredient of Wegovy) mimics the GLP-1 hormone, which your body releases naturally after eating. GLP-1 plays several roles in appetite regulation, including:

• Slowing gastric emptying (meaning food stays in your stomach longer after a meal, helping you feel full).
• Acting on appetite centres in the brain to reduce hunger.
• Enhancing insulin secretion to help regulate blood sugar.

Many people taking Wegovy describe a noticeable reduction in what’s sometimes called “food noise” — the persistent background thoughts about food and eating that can make weight management so difficult. By addressing these biological drivers of overeating, Wegovy may help reduce appetite and food intake, although people respond differently.

How Much Weight Can You Lose on Wegovy?

The clinical evidence for Wegovy comes primarily from the STEP trial program, which was a series of large, randomized, placebo-controlled studies.

In the foundational STEP 1 trial, 1,961 adults without diabetes took Wegovy or a placebo for 68 weeks alongside lifestyle changes. The results were significant: participants on Wegovy lost an average of 14.9% of their body weight (compared to just 2.4% for those on placebo). In practical terms, that’s an average loss of roughly 15 kg (33 lbs).

Looking at specific weight loss outcomes from STEP 1:

• Approximately 86% of patients lost at least 5% of their body weight
• 69% lost at least 10% of their body weight
• About half lost 15% or more
• Roughly one in three participants lost at least 20% of their body weight

Do the Weight Loss Results from Wegovy Last?

A common concern with weight loss medications is whether the results hold up over time. The STEP 5 trial addressed this directly by following patients being treated with Wegovy for two full years. The trial found that 104 weeks after starting treatment, participants on Wegovy maintained an average weight loss of 15.2% of their original body weight.

However, obesity is a chronic metabolic condition, and research shows that stopping GLP-1 medications like Wegovy, Ozempic and Mounjaro can lead to significant weight regain. 

Weight Regain After Stopping Wegovy

In the STEP 1 Extension trial, researchers followed patients for a full year after they stopped taking Wegovy. They found that participants regained an average of two-thirds of their prior weight loss within 12 months of stopping the medication, and their cardiovascular improvements also reverted toward baseline.

A recent comprehensive 2026 meta-analysis confirmed these findings. While the study looked at a wide range of weight loss medications, it found that patients who stopped taking newer GLP-1s like Wegovy regained weight at a rate of about 0.8 kg (1.8 lbs) per month, projecting a return to their starting weight within 1.5 to 2 years. 

These findings support the medical consensus that Wegovy is designed as a long-term therapy, and also highlight the importance of having a comprehensive lifestyle change and maintenance plan in place.

Wegovy and Heart Health: The SELECT Trial

Perhaps the most important clinical development for Wegovy is the SELECT trial — a landmark study that goes beyond weight loss entirely.

The SELECT trial enrolled over 17,600 adults across 41 countries. These were non-diabetic patients who were overweight or obese and had established cardiovascular disease (such as a prior heart attack, stroke, or peripheral artery disease). 

Over an average follow-up of nearly 40 months, participants on Wegovy experienced a 20% relative reduction in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) compared to placebo.

Potential Benefits of Wegovy Beyond Weight Loss 

The SELECT trial findings are particularly notable because the cardiovascular benefits appeared early in the trial, before participants had achieved their maximum weight loss. 

A prespecified SELECT analysis estimated that reduced waist circumference explained about one-third of the cardiovascular benefit. It did not establish which mechanisms explained the remainder.

Implications for Insurance Coverage

The SELECT trial results have significantly shifted the Canadian insurance landscape.

Back in 2022, Canada’s Drug Agency (CDA-AMC) initially recommended against public reimbursement for Wegovy, citing a lack of data on long-term health outcomes. However, based on the strength of the SELECT trial, the agency reversed its stance in July 2025. 

The CDA-AMC now officially recommends that public drug plans reimburse Wegovy for patients with a BMI of 27 or greater who also have established cardiovascular disease. This recommendation is conditional and is not confirmation that a provincial plan has listed Wegovy or that an individual prescription will be covered.

Wegovy vs Ozempic

Since both medications contain semaglutide, the Ozempic vs Wegovy question comes up frequently. Here are the key differences.

• Approved use: Ozempic has Canadian indications for type 2 diabetes. Wegovy is approved for chronic weight management in eligible patients, non-fatal heart-attack risk reduction in specified adults, and conditionally for specified non-cirrhotic MASH. Off-label prescribing does not change a product’s authorization.
• Dosing: Wegovy’s usual maintenance dose is 2.4 mg weekly after escalation. Ozempic has a different dose schedule. Products and trials should not be compared by dose alone; results in different study populations do not prove how much more weight an individual will lose.
• Pen design: The Canadian Wegovy monograph includes single-use and multi-use FlexTouch pens. Follow the instructions for the exact device dispensed; do not assume that every semaglutide pen works identically.
• Cost: Compare pharmacy quotes for the exact product, dose and days supplied, including fees, insurance and manufacturer savings. Generic approvals and brand savings programs have changed the early-2026 price comparison.

If you are currently using Ozempic off-label for weight loss, speak with your prescriber about the appropriate product and dose before switching.

How Much Does Wegovy Cost in Canada?

Cost is one of the most common concerns for Canadians considering Wegovy. Because this is a long-term medication, understanding Wegovy price and coverage options is essential for your planning.

Wegovy Cost Without Insurance

Wegovy cost without insurance depends on your pharmacy and any savings program. Novo Nordisk’s Canadian savings program currently says some patients paying out of pocket may pay as little as CAD $300 for a 28-day supply. Pharmacy markups vary and dispensing fees are excluded; this is not a guaranteed price for everyone.

The final price can vary based on:

• Dispensing fees and pharmacy markup: Ask whether these are included in the quote.
• Product, dose and supply: Confirm the exact prescription and number of weekly doses.
• Coverage and savings: Check eligibility, deductibles and copayments. Manufacturer programs can change or stop.

Note: Confirm current pricing directly with your pharmacy before filling the prescription.

Is Wegovy Covered by Insurance in Canada?

The only way to know for sure if Wegovy is covered by your insurance is to check with your provincial drug plan or private insurer. However, below are some general guidelines around what to expect.

Private insurance

Some private plans cover Wegovy, but coverage is not universal and depends on the plan and prescribed use.

Some plans require Prior Authorization (PA). Your prescribing doctor may need to submit a standardized PA form confirming:

1. A qualifying BMI (typically 30+, or 27+ with a weight-related condition).
2. A history of previous weight management attempts.
3. Evidence that you are using the medication alongside lifestyle changes (diet and exercise).

Your remaining cost depends on the plan’s deductible, reimbursement rate, limits and any eligible manufacturer savings. Approval does not guarantee a particular copayment.

Provincial Drug Plans

Historically, provincial drug plans (such as ODB in Ontario or BC PharmaCare) have not covered Wegovy for general weight management. However, a major shift occurred in July 2025, when Canada’s Drug Agency (CDA-AMC) issued a landmark recommendation. 

CDA-AMC advised that public plans should reimburse Wegovy for adults with a BMI of 27 or greater who also have established cardiovascular disease. A reimbursement recommendation does not itself add a medicine to a provincial formulary. Check the current product listing and authorization criteria with your pharmacist or provincial plan.

Generic Wegovy in Canada

Health Canada authorized Sevmia, an Apotex generic version of Wegovy, on June 29, 2026. This is separate from generic Ozempic approvals for type 2 diabetes.

Approval does not establish local stock, substitution rules, coverage or a guaranteed monthly price. Ask your pharmacist about the exact product and dose. Read our Generic Ozempic Canada guide for the distinction between these products.

Wegovy Dosing Schedule

Wegovy uses a gradual dose escalation over 16 weeks to help your body adjust and minimise side effects. The official dosing schedule works as follows:

• Weeks 1–4: 0.25 mg once weekly
• Weeks 5–8: 0.5 mg once weekly
• Weeks 9–12: 1.0 mg once weekly
• Weeks 13–16: 1.7 mg once weekly
• Week 17 onward: 2.4 mg once weekly (maintenance dose)

Check the strength and device on every prescription. If a dose is not tolerated during escalation, your prescriber may delay the next increase for four weeks; do not change the schedule yourself.

Inject Wegovy subcutaneously (under the skin) in your abdomen, thigh, or upper arm, and rotate the injection site each week. You can take your weekly dose on any day, at any time, with or without food.

What to Do If You Miss a Wegovy Dose

If you miss a dose of Wegovy, take it as soon as you remember — provided your next scheduled dose is at least 48 hours away. If the next dose is less than 48 hours away, skip the missed dose and simply resume your regular schedule on your normal day.

Important Safety Note: If you miss more than two consecutive doses, speak with your prescriber before restarting. They may recommend resuming the schedule or restarting dose escalation to reduce gastrointestinal side effects.

Side Effects of Wegovy

Like all GLP-1 receptor agonists, Wegovy’s most common side effects are gastrointestinal. In the STEP clinical trials, the most frequently reported issues were:

• Nausea (affecting approximately 44% of patients)
• Diarrhea (30%)
• Vomiting (25%)
• Constipation (24%)

These numbers can sound concerning at first glance, but context matters. 

The majority of Wegovy side effects are mild to moderate, and they tend to peak during the dose escalation phase (particularly when moving up to a new dose level). These effects usually improve over time. Contact your clinician if symptoms persist or make it difficult to eat or stay hydrated. 

Tips for Managing Wegovy Side Effects

To reduce the likelihood of gastrointestinal discomfort, consider eating smaller, more frequent meals rather than large ones, avoiding greasy, fried, or heavily spiced foods (especially during dose increases), staying well hydrated, and eating slowly. These are the same strategies recommended for patients on Ozempic and Mounjaro.

Who Should Not Take Wegovy?

Do not use Wegovy with a personal or family history of medullary thyroid carcinoma, MEN 2, or a serious allergy to its ingredients. Do not combine it with another semaglutide or GLP-1 medicine. Tell your clinician about pancreatitis, gallbladder disease or severe stomach-emptying problems so these can be assessed.

Pregnancy warning: Do not use Wegovy during pregnancy or breastfeeding. Stop at least two months before a planned pregnancy.

Any baseline blood tests depend on your medical history and assessment. Seek urgent care for severe persistent abdominal pain or a serious allergic reaction. See the Canadian prescribing and patient information.

Wegovy Pill in Canada

Oral Wegovy is a daily semaglutide tablet, distinct from the weekly injection. A 2026 manufacturer announcement described the 25 mg oral product’s regulatory review in Europe.

Approval or availability in another country does not establish Canadian authorization. The Canadian Wegovy monograph linked in this article describes injectable pens. Ask your pharmacist to verify the current Canadian authorization and availability of the exact oral product; do not substitute tablets for an injection. Oral and injectable semaglutide have different administration instructions.

Frequently Asked Questions About Wegovy

Is Wegovy available in Canada?

Yes. Wegovy has been approved by Health Canada and is available by prescription at Canadian pharmacies. However, supply can fluctuate depending on demand, so check with your pharmacy about current availability.

How much does Wegovy cost per month in Canada?

The price depends on the pharmacy and coverage. Novo Nordisk’s Canadian savings program says some patients may pay as little as CAD $300 per 28-day supply, excluding dispensing fees and subject to pharmacy markup. Confirm your quote and eligibility.

How much is Wegovy in Canada without insurance?

Ask for an out-of-pocket quote including fees, and ask whether the manufacturer savings program applies. A monthly price advertised by a program is not a guarantee for every patient.

When will generic Wegovy be available in Canada?

Health Canada authorized Sevmia, a generic Wegovy product, on June 29, 2026. Check current pharmacy stock, prescribed dose, coverage and substitution requirements.

Is Wegovy covered by insurance in Canada?

Some private plans provide coverage, often with prior authorization. Public coverage depends on the exact provincial listing and criteria. A reimbursement recommendation alone does not confirm that your prescription is covered.

What’s the difference between Wegovy and Ozempic?

Both contain semaglutide but their approved uses, doses and devices differ. Wegovy has a chronic weight-management indication, while Ozempic has type 2 diabetes indications. Discuss the appropriate product with your prescriber and follow its specific instructions.

Wegovy Canada — Is It Right for You?

Wegovy represents a significant step forward in medically supported weight management for Canadians. With strong clinical evidence showing sustained weight loss of approximately 15%, cardiovascular benefits for high-risk patients, and the authorization of a generic Wegovy product, it’s becoming an increasingly accessible option.

That said, Wegovy in Canada is a prescription medication that requires medical supervision, any tests appropriate to your assessment, and a gradual dose escalation over several months. It works best as part of a comprehensive plan that includes dietary changes and physical activity — not as a standalone solution.

If you’re considering Wegovy or want to discuss whether it’s the right fit for your situation, speaking with a healthcare provider is the best first step. The physicians on the Walk In platform can assess eligible patients in selected communities and discuss treatment options. Appointment availability varies; treatment depends on clinical assessment.

Speak With a Virtual Doctor About Weight Loss Treatment